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COMPENSATORY reaction of liver tissue after dam-
age is a typical hepatic response on which most of 
modem hepatic surgical therapy relies. I Characteristic 
changes in the rate of cellular proliferation (hyperplasia) 
and hepatocyte volume (hypertrophy) are observed every 
time a part of the liver is removed or whenever an 
impairment occurs in the blood supply to the organ (isch-
emic damage). 
Substances which are able to support the liver in those 
reparative processes or which can prevent hepatocellular 
damage from different causes are referred to as ht!pa-
totrophic. Using this definition. hepatotrophic qualities 
have been associated with several endogenous SUbstances. 
including insulin2•3 and cytosolic extract from regenerating 
Iivers.4., More recently. a striking hepatotrophic eft"ect has 
been demonstrated for CyA.6 
In this study, the hepatotrophic eft"ects of the new 
immunosuppressive agent. FK 506. were tested using an 
experimental model (Eck-fistula in dogs) that allows hepa-
tocyte renewal and hypertrophy to be separated.7 The 
results were then compared with those obtained with CyA 
under the same experimental conditions.6 
MATERIALS AND METHODS 
A functional end-t~side ponacaval shunt (Eek-fistula) was cre-
ated in 21 adult female beqle dOllS weiping 10 . .5 = 2.3 kg with the 
surgical technique previously described",7 (Fig I). Oilferent doses 
of FK 506 were then continuously infused for 4 days into the left 
branch of the ponaJ vein. Four group of animals were studied: 
group I (n = 4) received an infusion of the vehicle used to 
Pump 
~ FK-506 
FIg 1. Surgical model of Eck-Fistula (porl8CavaJ shunt) WIltI 
external continuous infusion of CyA and FK 506. 
solubilize FK 506 (HCO-60. polyoxyethiJaled hydrogenated cas-
trol oil and o-mannitol) at the rate equivalent to the FK .506 
infusion rate of 0.01 mg/kg/d (two animals) and I mg/kg/d (two 
animals); group 2 (n = 6) received FK 506. 0.01 mg/kg/d for 4 
days; group 3 (n - 6) received FK 506. 0.1 mglkgld for 4 days; aDd 
group 4 (n - 5) received FK 506. I mglkgld for 4 days. 
At the end of the infusion period. intravenous ['H)-thymidine 
was il\iected 2 houn before biopsy specimens were obtained from 
left and ript lobes of the liver. 
As an index of hepatocyte reaeneration. the number of mitosis 
was determined by countinl the number of ('H)-thymidine-labeled 
nuclei per 1.000 hepatocytes. The volume of individual hepatO-
cytes (index of hypertrophy) was determined by determination of 
hepatocyte cell size units.l.J 
All data are reponed as mean values = standard deviation (SO). 
For analysis of variance (ANOV A). the two main populations 
were control d~ (receiving only the vehicle) and FK .506-trealed 
dOlI. An F test value of >3.0 (P < 0.01) was considered 
sipificant. The comparison between individual experimental 
groups (dilferences rightlleft and CyAlFK 5(6) was carried out 
using the Student's I test. A probability of <0.05 was considered 
to be sipificant. 
RESULTS 
The positive eft"ect of FK 506 on cell renewal and on 
restoration of the hepatocyte normal size is summarized in 
Tables I and 2. 
Control Animals 
The FK 506 vehicle had no significant eft"ect and the 
hepatocytes suft"ered the typical changes observed after 
Eck-fistula.7 There were slightly more than 4 mitoses/I.OOO 
hepatocytes. The cells were irregular in shape. depleted of 
glycogen. and shrunken in size. The cell size of the 
hepatocytes of this group ranged between 0.104 and 0.110. 
The normal value in dogs is 0.160 :t: 0.01 U (Table 2). 
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Table 1. Hepatocyte Mitoses by Autoradiography After Intniportal Contlnuouslntuslon of FK 506 Into the Left Portal Vein of 
Eck.flstule Dogs 
Group No. of FK 506 Infutian 
No. of Labeled Hepatocyles Per 1.000 Hepatocylest (mean :!: SO) 
No. EX!IIIimenII RatI' (lTIgI1cgId) Right lobIa left lobes PVu. 
1 4 o (controIs)* 4.25 ~ 0.33 4.47 ~ 0.20 NS 
2 6 0.01 4.71 ~ 0.63 5.46 ~ 0.36 NS 
3 6 0.1 5.16 ~ 0.44 5.98 ~ 0.33 0.05 
4 5 5.48 ~ 0.78 8.94:!: 0.83 0.003 
'AHOVA (Ill FK 506 dogs __ conIIOIIl: F • 12.0325. P • 0.0004. 
fin nonnaI dogI. the mitoMe in left and righllobeI.,. 1.6 :!: 0.4.2.3.' The inCIe_ in miIOeea caused by Eck·'istula is known 10 be Iignific:ant. 
*Control dogs ~ 0I'Itf the veIIicIe 01 FK 506 (_ text). 
Table 2. f~ SIa After Intr'IIpOrW/ ContInuous Infusion of CyA In Eck.flstule Dogs 
Group No. of FK 506 Infusion 
No. EJIPIIimenII Rail' (1TIgI1cgId) 
1 4 o (controls) 
2 6 0.01 
3 6 0.1 
4 5 
• ANOVA (Ill FK 506 dogs versU8 c:onIJOiIl: F - 20.034. P - 0.001. 
tin nonnaI CIOgS.1'Ie!InIcyIe liD unitS _ 0.160:!: 0.01.203 •• 
FK 506 Infusion 
A dose response relation was evident in the increase in 
mitotic index (Table I) and the hepatocyte size (Table 2) in 
the FK 506-treated dogs. The increased hepatocyte mito-
ses as well as the restoration of nonnal hepatocyte size 
was most striking in the lobes infused with FK 506. but 
there was also a spillover effect to the right lobes. 
The right (non-infused) lobes had changes similar to. 
although less than. those in the left (infused) lobes (Tables 
I and 2). The results observed with FK 506 were similar to 
those previously reportedf> with CyA (Table 3). although 
FK 506 was infused at one fourth to one sixth of the dose 
used for CyA. Besides the prevention of cellular atrophy 
after Eck·fistula. high-dose FK 506 (I mglkgld) was also 
able to induce a significantly stronger cell renewal than 
that observed with CyA (Table 3). 
DISCUSSION 
In effect. the Eck-fistula model used in the present studies 
splits the liver into two fragments that differ only by what 
is infused into one of the two main branches of the portal 
eel SIre UnitS (Mean :!: SO)f 
Rightlobla left lobIa 
0.104 :!: 0.018 0.110:!: 0.016 
0.103 :!: 0.074 0.111 :!: 0.083 
0.113:!: 0.081 0.137 :!: 0.076 
0.134 :!: 0.059 0.161 :!: 0.011 
vein. Therefore. hepatotrophic actions of a given sub-
stance can be studied comparing. in the same liver. hepa-
tocytes from the infused (treated) lobes versus hepatocytes 
from non-infused (control) lobes. With this model. the 
portal route of drug delivery which follows oral ingestion 
of Cy A or FK S06 was simulated in the left lobes but not in 
the right lobes. 
Hepatic regeneration is augmented by CyA.8• IO tn Eck-
fistula dogs. Cy A prevents hepatocellular atrophy and 
restores the normal cellular size and morphology and. in 
addition. it augments the low-grade hyperplasia character-
istic of this modeL/) The effects of FK 506 are much the 
same. With both drugs there appear to be no harmful 
consequences of delivering the drugs directly to the liver. 
In fact. the infused (left) lobes exhibited higher mitotic 
index and healthier hepatocytes when compared with the 
control (right) lobes. 
There were no statistically significant differences be-
tween results obtained with FK 506 and CyA (Table 3). 
although FK 506 was infused at one fourth to one sixth the 
dosage used for CyA. Therefore. a stronger hepatotrophic 
Table 3. Cornpertaon Between Hepltotrophlc QWIIJtIH 0' FK SOland CyA" 
Group COmpenson 
FK 506 eyA 
(rrqllgldl (mIJIIIOIdl Miloais Cal Size UnolS 
ControlS v Controls NS NS 
001 v 0.06 NS NS 
0.1 v 0.6 NS NS 
NS (normal value restored 
v 4 <0.003 in boItI1tealmenlS) 
Noll: FK 50811u • llepalOllOllhC elect more ..... then CyA on. molar baM. AIIIIgII it'I"- ,. ... FK 5061ur1t1er...,.... the eel ,.,... MMff1Cuff*~ 01 liver 
,..,..,.,.1Ion. 
'ComcIeIe data on CyA .,. reoonecIln I8feNnrle a. 
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elfect of FK S06 was present with FK S06 versus eyA on 
a molar basis. 
The hepatotrophic (liver-supponing) qualities of FK S06 
are in accord with the clinic:al observations about the value 
of this new immunosuppressive agent for salvage of nor-
mal liver grafts which were severely damaged by ischemic 
and immunologic reactions. 1 1.12 
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